These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15883289)

  • 1. Noninfectious uveitis: a scarcity of randomized clinical trials.
    Okada AA
    Arch Ophthalmol; 2005 May; 123(5):682-3. PubMed ID: 15883289
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis.
    Murphy CC; Greiner K; Plskova J; Duncan L; Frost NA; Forrester JV; Dick AD
    Arch Ophthalmol; 2005 May; 123(5):634-41. PubMed ID: 15883282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine.
    Sloper CM; Powell RJ; Dua HS
    Ophthalmology; 1999 Apr; 106(4):723-8. PubMed ID: 10201592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising immunosuppression.
    Schafer DF; Sorrell MF
    Lancet; 2002 Oct; 360(9340):1114-5. PubMed ID: 12387953
    [No Abstract]   [Full Text] [Related]  

  • 5. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis.
    Murphy CC; Greiner K; Plskova J; Frost NA; Forrester JV; Dick AD
    Br J Ophthalmol; 2007 Feb; 91(2):154-6. PubMed ID: 16973657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in heart and lung transplantation immunosuppression: tacrolimus versus cyclosporine.
    Kobashigawa JA
    Transplant Proc; 1998 Jun; 30(4):1095-7. PubMed ID: 9636445
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with cyclosporine in endogenous uveitis posterior.
    Hesselink DA; Baarsma GS; Kuijpers RW; van Hagen PM
    Transplant Proc; 2004 Mar; 36(2 Suppl):372S-377S. PubMed ID: 15041371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.
    Nguyen QD; Merrill PT; Sepah YJ; Ibrahim MA; Banker A; Leonardi A; Chernock M; Mudumba S; Do DV
    Ophthalmology; 2018 Dec; 125(12):1984-1993. PubMed ID: 30060978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis.
    Kilmartin DJ; Forrester JV; Dick AD
    Ocul Immunol Inflamm; 1998 Jun; 6(2):101-9. PubMed ID: 9689640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
    Nussenblatt RB; Peterson JS; Foster CS; Rao NA; See RF; Letko E; Buggage RR
    Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin or tacrolimus: which agent to choose?
    Danovitch GM
    Nephrol Dial Transplant; 1997 Aug; 12(8):1566-8. PubMed ID: 9269630
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine: advantages versus disadvantages vis-à-vis tacrolimus.
    Maes BD; Vanrenterghem YF
    Transplant Proc; 2004 Mar; 36(2 Suppl):40S-49S. PubMed ID: 15041305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal drugs for the treatment of noninfectious posterior and intermediate uveitis.
    Imrie FR; Dick AD
    Curr Opin Ophthalmol; 2007 May; 18(3):212-9. PubMed ID: 17435428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 15. The TMC study.
    Davies MH; Millson CE; Breslin NP
    Lancet; 2003 Jan; 361(9354):346; author reply 347. PubMed ID: 12559886
    [No Abstract]   [Full Text] [Related]  

  • 16. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
    Lowder C; Belfort R; Lightman S; Foster CS; Robinson MR; Schiffman RM; Li XY; Cui H; Whitcup SM;
    Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.
    Dick AD; Azim M; Forrester JV
    Br J Ophthalmol; 1997 Dec; 81(12):1107-12. PubMed ID: 9497474
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents.
    Walton RC; Nussenblatt RB; Whitcup SM
    Ophthalmology; 1998 Nov; 105(11):2028-34. PubMed ID: 9818601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine and tacrolimus in dermatology.
    Cather JC; Abramovits W; Menter A
    Dermatol Clin; 2001 Jan; 19(1):119-37, ix. PubMed ID: 11155577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normative comparison of patient-reported outcomes in patients with noninfectious uveitis.
    Naik RK; Rentz AM; Foster CS; Lightman S; Belfort R; Lowder C; Whitcup SM; Kowalski JW; Revicki DA
    JAMA Ophthalmol; 2013 Feb; 131(2):219-25. PubMed ID: 23411886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.